Jianpi Shufei Granule for Early-stage Chronic Obstructive Pulmonary Disease: a Multicenter, Randomized, Placebo-controlled Trial

Guangdong Provincial Hospital of Chinese Medicine0 个研究点开始时间: 待定最近更新: 2023年2月20日

适应症

试验速览

暂无简介。

•?Patients who are aged 40–85 years; ?Patients who meet the diagnostic criteria of COPD, stage I-II, with stable stage; ?Patients who meet the Chinese medicine syndrome classification of Qi deficiency and phlegm obstruction; ?Patients who sign the written informed consent form.

•?Patients with asthma,bronchiectasis,obstructive sleep apnea syndrome,lung malignant tumors or active pulmonary tuberculosis;?Chinese medicine syndrome based on Yin deficiency;?Patients with acute exacerbation of COPD within 4 weeks before enrollment;?Patients with history of allergies or hypersensitivity for any research drug component, or the researcher believes that it is known to have a disease that should not be participated in research;?Those who cannot complete the lung function test; ?Long-term of traditional Chinese medicine diet (astragalus, ginseng) and other Chinese medicinal materials);?Patients with severe cardiovascular, cerebrovascular, liver and kidney disease;?Alanine aminotransferase (ALT), aspartate aminotransferase (AST) or serum creatinine (Scr) exceed 1.5 times the upper limit of normal value;?Poor compliance;?Patients who have received any experimental drug treatment within 1 month;?Patients who Participated in or plan to participate in other clinical trials.

发起方

Guangdong Provincial Hospital of Chinese Medicine